Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen
Francesco Perri(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Laura Cella(Institute of Biostructure and Bioimaging), Sara Falivene(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Salvatore Pisconti(Ospedale SS. Annunziata), Paolo Muto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Carlo Buonerba(CTO Andrea Alesini), Manuel Conson(Institute of Biostructure and Bioimaging), Antonella Licchetta(Ospedale SS. Annunziata), Giuseppe Di Lorenzo(Saint Camillus International University of Health and Medical Sciences), Mario Giuliano(Regione Campania), Vincenzo Ravo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Roberto Pacelli(Institute of Biostructure and Bioimaging), Antonio Gnoni(Ospedale SS. Annunziata), Concetta Schiavone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Carla Cavaliere(Ospedale di Belcolle), Carmine D’Aniello(Ospedale SS. Annunziata), Giuseppina Della Vittoria Scarpati(University of Naples Federico II)
Cited by 9
Related Papers
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268